Medical Marijuana, Inc. and our portfolio of companies in the cannabis industry were once again in the news this week as CBD products continue to grow in popularity.
A Company of Firsts®, Medical Marijuana, Inc. is once again driving the CBD oil industry by encouraging smart cannabis regulation, supporting cannabis advocacy, and bringing our line of CBD products to new markets around the world. Continue reading for our biggest stories of the past week.
Latest in Latin American Expansion
News of Medical Marijuana, Inc.’s continued growth in the Latin American CBD market was featured in a number of media outlets this past week after Argentina approved THC-free RSHO-X for import by patients in the country.
Coverage of this news was provided in Benzinga. The piece emphasized Medical Marijuana, Inc.’s role as a leader in this market.
In the article, Medical Marijuana, Inc. CEO Dr. Stuart Titus was quoted saying, “As legislation continues to rapidly change, the Latin American market has become a significant opportunity for us to expand global access to CBD. We hope to continue to educate citizens and government officials in Argentina on the many therapeutic benefits of CBD and we hope that the success we see with patients there will lead to us gaining import permits in other Latin American countries as well.”
Medical Marijuana, Inc.’s import approval by Argentina was also covered in these outlets.
Athletes Advocating for Cannabis Use
A pair of spokespersons from the Medical Marijuana, Inc. family of companies were featured as part of an article in LedeTree.
Former NFL Pro Bowler Christian Okoye and UFC fighter Liz Carmouche were included in the article as vocal advocates for CBD use among athletes. Both were in New York recently for the Cannabis World Congress & Business Expo, one of the largest cannabis industry events of the year.
There, they participated in a panel discussion on the advantages of CBD products for athletes. The pair of athletes shared their personal experience using CBD products each day and promoted the potential for CBD to be added to the training and recovery routines of athletes.
Vice President of HempMeds® Brasil Interviewed
Caroline Heinz, VP of HempMeds® Brasil, a subsidiary of Medical Marijuana, Inc. sat down to answer questions about CBD and its place in the healthcare system in Brazil. This interview was linked to Autism Pride Day on June 18th, which was started to raise awareness for the rights of those on the Autism spectrum.
Heinz described the basics of CBD, its interaction with the human body through the endocannabinoid system, and how it is used in Brazil as a prescription medication. She also answered questions about the safety of CBD products from HempMeds® Brasil.
The Guardian Features Real Scientific Hemp Oil in Coverage of Cannabis Oil
The Guardian, one of the United Kingdom’s most widely read media outlets provided in-depth coverage into cannabis oil and its potential in healthcare around the world.
The article clearly defined the line between the hemp and marijuana plants and their major chemical compounds, CBD and THC, discussed their legality in countries around the world, and explored the advantages of the medical use of cannabis.
In this article, the RSHO brand of CBD oil was included in the article as the featured image, giving immense exposure for HempMeds® Brasil, the Medical Marijuana, Inc. portfolio company mentioned in the image’s caption.
Oracle Dispatch Covers Medical Marijuana, Inc. Response to DEA Announcement
Popular business and investing site, Oracle Dispatch looked at our response to the DEA recent announcement that CBD products created from hemp and in compliance with the Controlled Substances Act are legal for distribution in the U.S.
The piece says of Medical Marijuana, Inc., “As we get further and further into the process of delineating the twists and turns of a policy and protocol for emerging industries surrounding the cannabis patch, Medical Marijuana, Inc. (OTCMKTS:MJNA) is one stock that seems to find itself constantly in the spotlight. Ever the activist organization, this is a spot the company is more than willing to occupy.”
The article also takes a close look at Medical Marijuana, Inc.’s role as an innovator and market creator in the CBD oil industry. Our company understands the role regulation of the cannabis plant plays in our business. In the article, Medical Marijuana, Inc. CEO Dr. Stuart Titus is quoted saying, “We urge Congress to pass the 2018 Farm Bill, which would permanently remove hemp and hemp products from the purview of the Controlled Substances Act.”
>View original article
Author: Jeffrey Stamberger